Biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform
Location: Switzerland, Zurich, Schlieren
Total raised: $26.280316M
Investors 2
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 18.11.2013 | - | $26.280316... | - | startuptic... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 03.12.2015 | Kuros and ... | Cytos is listed on the main ... | Financing | - | startuptic... |
| 12.08.2015 | Checkmate ... | Checkmate Pharmaceuticals oper... | - | - | medcitynew... |
| 14.04.2014 | Cytos on t... | Cytos Biotechnology AG (SIX:... | - | - | startuptic... |
| 18.11.2013 | Cytos rais... | The rights offering was over... | - | - | startuptic... |
| 23.03.2012 | Cytos to r... | The new funds will recapital... | - | - | startuptic... |
| - | Checkmate ... | The name of the company’s pret... | - | - | medcitynew... |